Chemistry Faculty Publish SCI Q2 Research on Anticancer Compounds

Anurag University congratulates Dr. Savita Belwal, Professor & Head, Department of Chemistry, and Dr. E. Laxminarayana, Professor, Department of Chemistry, on the publication of their research paper titled "Synthesis and Biological Evaluation of Aryl (benzofuran-5-yl)-[1,2,4] Triazolo[4,3-a] Pyridine Derivatives as Anticancer Agents." The research has been published in Chemistry & Biodiversity (Wiley & Sons), a Q2, SCIE and Scopus-indexed international journal with an Impact Factor of 2.9 and an H-Index of 91.
The study focuses on the synthesis and biological evaluation of novel heterocyclic compounds with promising anticancer potential. By developing and assessing new aryl triazolopyridine derivatives, the research contributes to the ongoing search for effective therapeutic molecules that can support future advancements in cancer treatment and medicinal chemistry.
This achievement highlights the Department of Chemistry's commitment to impactful scientific research and reinforces Anurag University's focus on advancing innovation in pharmaceutical and chemical sciences through globally recognized publications.
Written By
By AU Media Team
More Stories You Might Like

Driving Intelligent Decisions with AI
Dr. N. Suresh Rao and Dr. B. V. V. Siva Prasad, CSE faculty members, have published research on an AI-driven decision support framework in a Scopus Q1 journal with a CiteScore of 3.4.

Building Skills Through Industry Exposure
Veeramreddy Ramya, III B.Tech AIML, has been selected for the Infosys Springboard Virtual Internship 7.0 – Batch 4, gaining an opportunity to strengthen her technical and industry-relevant skills.


